Rafarma Pharmaceuticals, Inc. announced that it has received $1.2 million in funding.
On December 12, 2013, Rafarma Pharmaceuticals, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1105 USD | +8.33% | +2.31% | -57.71% |
2021 | RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park | CI |
2021 | Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers | CI |